Nagendran Tharmalingam

11PUBLICATIONS
15CO-AUTHORS
Medical infection agents (incl. prions)Medical bacteriologyBiomolecular modelling and designMolecular medicineMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 19, 2026
Virulence Profiling of Multidrug-Resistant Clinical Staphylococcus aureus Isolates.

Amir Afzal Khan, Hamna Sadaf, Rabaab Zahra

|Mar 16, 2026
Candesartan cilexetil disrupts methicillin-resistant Staphylococcus aureus membrane and potentiates gentamicin and polymyxin B activity.

Nagendran Tharmalingam, Robert Wilson Kovacs, Suelen Scarpa de Mello

|Feb 25, 2025
Mefloquine reduces the bacterial membrane fluidity of Acinetobacter baumannii and distorts the bacterial membrane when combined with polymyxin B.

Nagendran Tharmalingam, Harikrishna Sekar Jayanthan, Jenna Port

|Jan 27, 2025
Mefloquine reduces the bacterial membrane fluidity of Acinetobacter baumannii and distorts the bacterial membrane when combined with polymyxin B.

Nagendran Tharmalingam, Harikrishna Sekar Jayanthan, Jenna Port

|Jun 24, 2022
Halogen-Based 17β-HSD1 Inhibitors: Insights from DFT, Docking, and Molecular Dynamics Simulation Studies.

Arulsamy Kulandaisamy, Murugesan Panneerselvam, Rajadurai Vijay Solomon

|Sep 28, 2021
Antifungal Activity of the Phenolic Compounds Ellagic Acid (EA) and Caffeic Acid Phenethyl Ester (CAPE) against Drug-Resistant Candida auris.

Fernanda Cristina Possamai Rossatto, Nagendran Tharmalingam, Iliana E Escobar

Pageof 2

Frequent Collaborators

3 joint publications

Eleftherios Mylonakis

2 joint publications

Rajendran J C Bose

1 joint publications

Beth Burgwyn Fuchs

1 joint publications

Frederick M Ausubel